
Bioconjugates such as antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), and other emerging formats present distinct analytical challenges. Variations in conjugation chemistry, linker-payload properties, and molecular structure require tailored analytical approaches to ensure meaningful characterization of purity, potency, and impurities.
This infographic highlights how Samsung Biologics combines platform methods with molecule-specific analytical optimization to address these challenges through three practical case studies.
Key highlights include:
Purity assessment by SE-HPLC: Resolving secondary interactions for clearer chromatographic profiles
Cell-based potency assay development: Improving dose-response consistency through method optimization
Free drug impurity assessment: Identifying sample preparation effects for more accurate impurity characterization
Discover how platform-based methods and molecule-specific analytical strategies can address complex bioconjugation challenges and support more efficient analytical development.

Bioconjugates such as antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), and other emerging formats present distinct analytical challenges. Variations in conjugation chemistry, linker-payload properties, and molecular structure require tailored analytical approaches to ensure meaningful characterization of purity, potency, and impurities.
This infographic highlights how Samsung Biologics combines platform methods with molecule-specific analytical optimization to address these challenges through three practical case studies.
Key highlights include:
- - Purity assessment by SE-HPLC: Resolving secondary interactions for clearer chromatographic profiles
- - Cell-based potency assay development: Improving dose-response consistency through method optimization
- - Free drug impurity assessment: Identifying sample preparation effects for more accurate impurity characterization
Discover how platform-based methods and molecule-specific analytical strategies can address complex bioconjugation challenges and support more efficient analytical development.